These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19042066)

  • 1. [Treatment of HIV facial lipoatrophy with a submalar porous polyethylene implant (Medpor)].
    Claude O; Domergue Than Trong E; Blanc R; Ascher B; Bagot M; Meningaud JP; Lantieri L
    Ann Chir Plast Esthet; 2009 Feb; 54(1):21-8. PubMed ID: 19042066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facial reconstruction using porous high-density polyethylene (medpor): long-term results.
    Niechajev I
    Aesthetic Plast Surg; 2012 Aug; 36(4):917-27. PubMed ID: 22684610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malar, submalar, and midfacial implants.
    Constantinides MS; Galli SK; Miller PJ; Adamson PA
    Facial Plast Surg; 2000; 16(1):35-44. PubMed ID: 11802345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary surgical management of HIV-associated facial lipoatrophy.
    Funk E; Bressler FJ; Brissett AE
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1015-22. PubMed ID: 16730549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of lipoatrophy and aging: volume deficits in the face.
    Coleman S; Saboeiro A; Sengelmann R
    Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restorative interventions for HIV facial lipoatrophy.
    Carey D; Liew S; Emery S
    AIDS Rev; 2008; 10(2):116-24. PubMed ID: 18615122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.
    Karim RB; de Lint CA; van Galen SR; van Rozelaar L; Nieuwkerk PT; Askarizadeh E; Hage JJ
    Aesthetic Plast Surg; 2008 Nov; 32(6):873-8. PubMed ID: 18551339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midface volume replacement with a transmaxillary implant.
    Burres S
    Aesthetic Plast Surg; 2005; 29(1):1-4; discussion 5. PubMed ID: 15580433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to treatment of HIV facial lipoatrophy.
    Jones D
    Skin Therapy Lett; 2005 Nov; 10(9):5-7. PubMed ID: 16292459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants.
    Mori A; Lo Russo G; Agostini T; Pattarino J; Vichi F; Dini M
    J Plast Reconstr Aesthet Surg; 2006; 59(11):1209-16. PubMed ID: 17046631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients.
    Rauso R; Curinga G; Santillo V; Corvo G; Tartaro G
    J Craniofac Surg; 2011 Sep; 22(5):1684-8. PubMed ID: 21959413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients.
    Loutfy MR; Raboud JM; Antoniou T; Kovacs C; Shen S; Halpenny R; Ellenor D; Ezekiel D; Zhao A; Beninger F
    AIDS; 2007 May; 21(9):1147-55. PubMed ID: 17502725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary experiences with Bio-Alcamid in HIV facial lipoatrophy.
    Ramon Y; Fodor L; Ullmann Y
    Dermatology; 2007; 214(2):151-4. PubMed ID: 17341865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid new formulation: experience in HIV-associated facial lipoatrophy.
    Bechara FG; Gambichler T; Brockmeyer NH; Sand M; Altmeyer P; Hoffmann K
    Dermatology; 2008; 217(3):244-9. PubMed ID: 18663308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malar and submalar augmentation.
    Binder WJ; Azizzadeh B
    Facial Plast Surg Clin North Am; 2008 Feb; 16(1):11-32, v. PubMed ID: 18063245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-M shaped septal encircling with Medpor reconstruction on crooked noses: personal technique and postoperative results.
    Emsen IM
    J Craniofac Surg; 2008 Jan; 19(1):216-26. PubMed ID: 18216692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High density porous polyethylene material (Medpor) as an unwrapped orbital implant.
    Chen YH; Cui HG
    J Zhejiang Univ Sci B; 2006 Aug; 7(8):679-82. PubMed ID: 16845724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.
    Silvers SL; Eviatar JA; Echavez MI; Pappas AL
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):34S-45S. PubMed ID: 16936543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of facial lipoatrophy by lipofilling in HIV infected patients: retrospective study on 317 patients on 9 years].
    Uzzan C; Boccara D; Lacheré A; Mimoun M; Chaouat M
    Ann Chir Plast Esthet; 2012 Jun; 57(3):210-6. PubMed ID: 22218365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.